Impact of the COVID-19 pandemic on primary brain tumor incidence and management: Decisions that went right.

ABSTRACT:

Background

The COVID-19 pandemic drastically altered cancer care. Prior reports demonstrated reduced screenings, diagnoses, and disrupted treatment regimens due to multifactorial reasons. We aim to analyze whether the same effects occurred within neuro-oncology.

Methods

This analysis included 70 131 patients with primary brain tumors from the SEER database from 2016 to 2021 identified via ICD10 code. The pre-COVID era was 2016-2019, peak-COVID was 2020, and post-COVID was 2021. Multivariate analysis was performed using logistic regression for binary variables and linear regression for continuous. Covariates controlled for were age at diagnosis, sex, and race. NCI SEER*Stat version 8.4.0 was used to calculate incidence rates age-adjusted to the 2000 US standard population and

SUBMITTER: Alfonzo Horowitz M 

PROVIDER: S-EPMC12448709 | biostudies-literature | 2025 Jan-Dec

REPOSITORIES: biostudies-literature